dear
editor
note
interest
recent
report
problem
diagnos
central
nervou
system
cn
infect
particularli
studi
compar
presenc
varicella
zoster
viru
vzv
dna
blood
cerebrospin
fluid
csf
patient
vzvrelat
neurolog
symptom
report
case
chronicrelaps
vzv
mening
episod
occur
frequent
debilit
regular
man
work
gener
practition
asylum
centr
present
histori
headach
fatigu
diffus
myalgia
lowgrad
fever
night
sweat
mood
disturb
symptom
wax
wane
everi
week
without
ever
fulli
resolv
never
includ
seizur
focal
neurolog
symptom
lost
kg
period
work
routin
expos
patient
variou
exot
chronic
infect
includ
varicella
outbreak
year
previous
gener
physic
examin
unremark
apart
limb
myalgia
specif
neither
neck
stiff
focal
neurolog
sign
detect
investig
chest
xray
echocardiographi
abdomin
ultrasound
normal
mribrain
show
nonspecif
lesion
deep
white
matter
compat
virchowrobin
space
full
blood
count
differenti
f
erritin
lipid
profil
thyroid
stimul
hormon
liver
function
serum
glucos
urea
electrolyt
erythrocyt
sediment
rate
normal
apart
mild
nonspecif
anaemia
serolog
test
hiv
cytomegaloviru
cmv
epsteinbarr
viru
herp
simplex
viru
hsv
brucella
borrelia
yersinia
toxoplasma
mycoplasma
pneumonia
either
neg
indic
past
infect
cerebrospin
fluid
examin
reveal
slightli
rais
total
protein
gl
low
glucos
mmoll
glucos
ratio
erythrocyt
seen
l
leucocyt
observ
primarili
lymphocyt
monocyt
polymeras
chain
reaction
test
csf
hsv
vzv
neg
csf
investig
use
immunoblot
show
intens
igg
band
csf
fewer
weaker
band
contemporan
serum
sampl
fig
csf
intrathec
vzv
igg
titr
vzvigg
index
indic
intrathec
vzvigg
synthesi
diagnosi
chronicrelaps
vzv
mening
made
cours
intraven
acyclovir
mg
td
given
patient
improv
treatment
mening
symptom
recur
everi
week
treatment
stop
repeat
csf
examin
symptomat
asymptomat
period
show
similar
profil
con
isoelectr
focus
vzv
igg
isoelectr
focus
pair
csf
serum
b
stain
igg
csf
show
promin
oligoclon
band
csf
absent
serum
consist
local
intrathec
synthesi
pattern
align
promin
band
centr
pattern
csf
allow
easi
comparison
although
distribut
band
appear
slightli
differ
csf
sampl
reflect
interassay
variabl
analyt
system
sampl
pair
run
differ
gel
anod
electrod
left
pair
csf
serum
imag
b
sampl
taken
approxim
two
month
apart
acut
ill
episod
temporan
serum
vzv
dna
pcr
mostli
neg
except
posit
low
level
copiesml
vzv
dna
repeat
isoelectr
focus
immuneblot
reveal
intrathec
oligoclon
igg
respons
togeth
vzvspecif
monoclon
igg
respons
fig
treatment
oral
valacyclovir
mg
td
day
follow
suppress
dose
valacyclovir
mg
bd
three
month
tri
howev
patient
continu
experi
mening
symptom
medic
treatment
continu
oral
valacyclovir
mg
bd
combin
monthli
vzv
hyperimmun
globulin
vzig
im
unit
although
improv
mening
symptom
recur
everi
week
sever
year
later
receiv
updat
patient
holiday
south
africa
mistakenli
receiv
dose
paediatr
varicella
vaccin
instead
regular
vzig
symptom
improv
week
return
netherland
basi
neurologist
suggest
zoster
vaccin
contain
least
pfu
plaqu
form
unit
vzv
per
dose
longerterm
symptom
relief
yet
avail
given
dose
paediatr
varicella
vaccin
contain
least
pfu
per
dose
instead
resolv
symptom
receiv
depot
corticosteroid
inject
shoulder
pain
mening
symptom
return
week
later
cours
paediatr
varicella
vaccin
remain
symptomfre
varicellazost
viru
remain
latent
neuron
cranial
nerv
dorsal
root
ganglia
entir
life
host
primari
infect
chickenpox
herp
zoster
shingl
common
form
vzv
reactiv
characteris
dermatom
rash
radicular
pain
rare
vzv
spread
spinal
cord
brain
occur
cn
complic
may
develop
without
concomit
zoster
rash
pattern
also
visibl
serum
sampl
ladderpattern
characterist
monoclon
antibodi
due
strong
stain
anod
leftmost
band
merg
absenc
band
control
immunoblot
use
celllin
without
vzv
b
show
igg
patient
csf
serum
highli
vzvspecif
vzv
seen
immunocompet
well
immunocompromis
patient
diagnosi
usual
confirm
posit
csf
vzv
dna
pcr
result
less
commonli
intrathec
detect
vzvspecif
igg
repeat
failur
detect
csf
vzv
dna
case
acut
episod
may
due
chronic
cours
diseas
similar
decreas
percentag
csf
hsv
pcrposit
case
seen
within
week
hsv
enceph
may
also
true
vzv
onset
symptom
patient
year
first
csf
vzv
pcr
perform
symptom
also
limit
viral
mening
rather
evolv
enceph
may
also
explain
neg
vzv
pcr
result
howev
extens
intrathec
vzv
igg
product
confirm
diagnosi
vzv
asept
viral
mening
find
distinctli
monoclon
intrathec
vzvspecif
igg
unusu
atyp
fig
normal
oligoclon
respons
requir
clear
viru
effici
therefor
patient
may
defect
vzvspecif
antibodi
affin
matur
ie
partial
immunolog
scotoma
vzv
explain
inabl
clear
ie
neutralis
viru
effici
allow
recurr
episod
mening
note
case
meet
bruyn
diagnost
criteria
mollaret
mening
patient
complet
symptomfre
episod
knowledg
chronicrelaps
varicella
zoster
viral
mening
period
previous
describ
remark
respons
multipl
dose
paediatr
varicella
vaccin
fortun
serendipit
patient
like
suffer
vzvspecif
antibodi
matur
deficit
appear
overcom
massiv
immun
stimul
provid
multipl
dose
paediatr
varicella
vaccin
whilst
case
rare
report
may
assist
manag
editor
would
like
take
opportun
comment
systemat
review
alen
et
al
author
pool
data
preval
patient
multidrugresist
tuberculosi
mdrtb
howev
found
preval
differ
extrem
among
total
number
psychosi
depress
report
n
b
baselin
inform
treatment
initi
report
c
divers
tool
appli
preval
estim
depress
diagnosi
standard
uniform
extract
event
number
tabl
studi
rang
lead
high
statist
heterogen
check
surprisingli
found
four
studi
report
preval
depress
mdrtb
treatment
one
studi
report
preval
baselin
other
report
incid
depress
advers
effect
mdrtb
treatment
tabl
author
may
care
distinguish
concept
preval
incid
addit
studi
adopt
differ
scale
diagnosi
criteria
preval
rate
may
chang
accord
criteria
recommend
pool
data
metaanalysi
hope
futur
studi
adopt
unifi
standard
depress
research
better
estim
preval
depress
mdrtb
treatment
conduct
metaanalysi
stata
calcul
incid
depress
advers
effect
mdrtb
treatment
result
show
incid
rate
confid
interv
fig
consid
result
may
provid
refer
clinic
doctor
author
discuss
caus
psychosi
may
cycloserin
addit
sever
studi
mention
depress
might
also
advers
effect
cycloserin
summar
appreci
author
hard
work
mistak
data
pool
estim
incid
rate
depress
advers
effect
mdrtb
treatment
perform
metaanalysi
futur
studi
need
estim
preval
none
dear
editor
previous
report
journal
earli
public
author
china
enforc
detect
import
zika
case
intern
airport
regard
continu
global
transmiss
zika
viru
zikv
februari
septemb
import
zikv
infect
case
detect
china
import
venezuela
surinam
guatemala
enp
counti
guangdong
china
fig
hometown
guangdong
resid
work
live
south
america
south
pacifica
countri
resid
maintain
perman
home
travel
frequent
enp
counti
zikv
endem
countri
south
america
south
pacifica
therefor
enp
consid
threaten
area
zikv
guangdong
china
due
high
incid
import
zika
case
addit
guangdong
provinc
hyperendem
area
arbovirus
locat
southern
china
aed
albopictu
aegypti
mosquito
encount
simultan
dengu
occur
annual
chikungunya
also
occasion
import
caus
local
outbreak
howev
whether
previous
import
zikv
within
return
expatriot
chines
enp
guangdong
china
result
unwar
local
transmiss
popul
still
remain
unknown
februari
octob
commun
base
serolog
surveil
studi
return
expatriot
chines
popul
conduct
enp
counti
guangdong
provinc
china
address
whether
popul
expos
zikv
import
expatriot
chines
randomli
select
guangdong
resid
work
live
south
america
south
pacifica
countri
return
enp
counti
inform
return
expatriot
chines
travel
total
male
femal
rang
year
old
inform
entryexit
inspect
quarantin
bureau
guangdong
provinc
travel
show
symptom
zikv
infect
either
fever
rash
arthralgia
conjunct
local
center
diseas
control
prevent
cdc
staff
contact
travel
time
arriv
enp
counti
phone
household
visit
blood
sampl
taken
local
hospit
upon
arriv
transfer
guangdong
provinci
cdc
serum
separ
zikv
rna
test
popul
choos
commun
enp
counti
import
zika
case
detect
neighbor
heshan
counti
fifti
kilomet
away
enp
oversea
chines
live
non
zikv
endem
area
southeast
asia
fig
popul
recruit
local
resid
travel
histori
zikv
endem
area
south
america
south
pacifica
countri
without
contact
histori
import
zika
case
final
total
resid
male
femal
rang
year
old
recruit
came
enp
heshan
counti
respect
blood
sampl
resid
taken
transfer
local
cdc
total
serum
sampl
collect
transfer
guangdong
provinci
cdc
zikv
rna
neutral
antibodi
detect
quantiti
zikv
rna
envelop
gene
determin
quantit
realtim
revers
transcript
pcr
qrtpcr
previous
report
zikv
rna
detect
among
serum
sampl
indic
acut
stage
infect
zikv
although
crossreact
bind
antibodi
commonli
detect
flavivirusimmun
serum
neutral
assay
specif
distinguish
antibodi
respons
variou
flavivirus
exposur
previous
thu
serum
antibodi
zikv
return
resid
determin
make
sure
whether
person
expos
zikv
vero
cell
base
microneutr
assay
zikv
chikv
denv
denv
result
indic
zikv
could
neutral
serum
sampl
return
person
ic
rang
travel
histori
south
america
south
pacif
area
tabl
twenti
one
zikv
antibodi
posit
serum
sampl
show
acrossneutr
effect
four
sampl
show
minor
crossneutr
effect
chikv
ic
rang
moreov
serum
sampl
return
person
show
minor
crossneutr
chikv
ic
rang
zikv
denv
surprisingli
one
serum
sampl
one
resid
enp
counti
show
significantli
neutral
abil
zikv
ic
chikv
ic
remain
resid
sampl
show
neutral
effect
zikv
chikv
well
denv
transmiss
infect
intern
travel
grow
health
issu
frequenc
import
infect
increas
china
recent
studi
report
profil
travelrel
infect
among
arriv
travel
mainland
china
highlight
increas
public
awar
potenti
risk
import
infect
inde
global
transmiss
zikv
suspect
intern
travel
endem
area
local
countri
address
recent
phylodynam
analysi
guangdong
china
airport
activ
screen
system
found
import
zika
case
indic
guangdong
high
risk
zika
transmiss
due
wide
distribut
compet
vector
zikv
aed
albopictu
aegypti
although
present
commun
base
followup
serolog
survey
found
expatriot
chines
return
zikv
endem
countri
ever
expos
zikv
none
zikv
case
acut
stage
accord
result
zikv
rna
detect
contrast
found
resid
exposur
zikv
addit
zikv
antibodi
posit
serum
sampl
return
popul
show
minor
crossneutr
effect
chikv
surpris
continu
circul
chikv
south
american
countri
therefor
travel
may
infect
chikv
return
china
howev
observ
crossneutr
effect
zikv
chikv
denv
among
resid
except
uniqu
suspect
asymptomat
zikv
chikv
case
want
declar
travel
histori
conclus
report
indic
although
number
zika
case
import
hyper
endem
area
arbovirus
guangdong
china
commun
base
surveil
popul
show
zikv
tent
import
guangdong
wherea
local
transmiss
establish
guangdong
china
highlight
control
strategi
taken
public
health
author
guangdong
probabl
prevent
onward
transmiss
zikv
area
recent
year
pathogen
transmiss
well
increas
potenti
human
infect
abil
avian
influenza
virus
aiv
document
journal
sinc
highli
pathogen
avian
influenza
virus
hpaiv
becom
enzoot
mani
countri
pose
seriou
challeng
poultri
industri
public
health
hpaiv
emerg
circul
poultri
caus
sporad
human
infect
china
sinc
hpaiv
circul
asia
north
america
europ
wild
bird
consid
natur
reservoir
aiv
play
import
role
viral
transmiss
studi
present
brief
character
three
hpaiv
differ
na
subtyp
isol
wild
bird
aiv
surveil
wild
bird
isol
three
strain
hpaiv
design
aanser
cygnoidesjiangxi
aanser
st
poyang
lake
jiangxi
provinc
shengtian
lake
shanxi
provinc
clarifi
genet
characterist
sequenc
gene
segment
three
virus
compar
influenza
viru
sequenc
genbank
pathogen
three
isol
addit
determin
chicken
duck
mice
viru
isol
fece
sampl
resuspend
pb
solut
antibiot
subsequ
inocul
specif
pathogenfre
spf
embryon
chicken
egg
describ
previous
rna
extract
use
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
full
genom
virus
sequenc
deposit
genbank
access
no
character
three
isol
determin
clade
distribut
base
ha
gene
sequenc
isol
belong
clade
fig
sequenc
analys
show
high
nucleotid
ident
ha
gene
three
virus
achickentong
hai
aorient
magpi
current
circul
asia
fig
assess
risk
likelihood
transmiss
avian
mammalian
speci
genotyp
marker
evalu
base
genom
sequenc
receptor
bind
site
ha
gene
three
hpaiv
contain
number
suggest
bind
prefer
avianlik
receptor
virus
share
four
six
amino
acid
chang
within
receptor
bind
site
rb
ha
specif
tabl
remark
ha
gene
three
isol
lack
nlink
glycosyl
site
posit
whose
absenc
consid
promot
receptor
bind
affin
guinea
pig
transmiss
mutat
within
rb
loss
glycosyl
site
residu
suggest
isol
confer
receptor
prefer
chang
mutat
relat
pathogen
mammal
detect
three
avian
isol
howev
substitut
intern
gene
identifi
includ
nine
eight
two
pa
three
mp
six
ns
potenti
enhanc
polymeras
activ
increas
virul
mammal
mutat
appear
confer
increas
receptor
bind
properti
also
greater
virul
hpaiv
thu
pose
increas
threat
public
health
evalu
pathogen
three
isol
chicken
group
ten
spf
chicken
intraven
inocul
ml
dilut
allanto
fluid
viru
mortal
observ
period
characterist
virus
highli
pathogen
chicken
present
tabl
evalu
pathogen
isol
duck
inocul
group
spf
duck
intranas
eid
viru
observ
mortal
period
characterist
virus
shown
tabl
data
clearli
indic
high
pathogen
virus
duck
determin
pathogen
virus
mammalian
host
inocul
balbc
mice
intranas
eid
viru
total
volum
five
inocul
mice
euthan
day
postinocul
pi
viru
titrat
lung
nasal
turbin
liver
brain
remain
mice
monitor
daili
weight
loss
mortal
total
week
intranas
administr
high
viru
titer
detect
lung
nasal
turbin
liver
brain
viru
identifi
lung
nasal
turbin
liver
brain
group
mice
show
sign
ill
observ
period
mice
group
inocul
isol
die
fig
howev
mortal
observ
group
fig
suggest
strain
highli
pathogen
mice
summari
character
three
hpai
virus
differ
na
subtyp
isol
appar
healthi
wild
bird
three
isol
highli
pathogen
chicken
duck
subtyp
show
high
pathogen
mice
mani
speci
wild
bird
longdist
dispers
migrat
capac
behavior
increas
likelihood
hpaiv
spread
present
seriou
threat
poultri
human
health
potenti
conflict
interest
na
gene
show
highest
similar
nucleotid
posit
except
similar
find
indic
na
gene
mainli
deriv
segment
major
parent
aduckzhejiang
underw
reassort
aduck
fig
estim
rate
nucleotid
codon
substitut
gather
sequenc
current
avail
subtyp
aiv
ncbi
gisaid
januari
march
divid
two
group
isol
analysi
uncorrel
relaxclock
bayesian
markov
chain
mont
carlo
method
use
beast
beast
analysi
show
mean
rate
ha
na
gene
nucleotid
substitut
decreas
compar
tabl
addit
mutat
rate
second
nucleotid
codon
within
open
read
frame
orf
ha
gene
rate
confirm
mutat
rate
doubl
tabl
interestingli
subtyp
aiv
belong
euras
lineag
contain
six
potenti
nglycosyl
site
includ
posit
nst
ngt
hpd
highest
probabl
densiti
posit
three
nucleotid
codon
e
scientif
notat
nat
nvt
ng
ngt
ha
protein
howev
mutat
amino
acid
posit
result
nst
nglycosyl
site
strain
disappear
new
nd
site
appear
protein
sinc
strikingli
codon
amino
acid
posit
one
nucleotid
aac
differ
nucleotid
agc
lead
mutat
might
relat
mutat
rate
second
nucleotid
codon
doubl
time
therebi
chang
nglycosyl
site
indic
viral
replic
adapt
subtyp
aiv
might
evolv
substanti
host
conclus
aiv
subtyp
ignor
low
pathogen
isol
rate
find
reveal
ha
na
gene
reassort
subtyp
aiv
mean
rate
second
nucleotid
codon
ha
gene
doubl
howev
although
mean
rate
ha
na
gene
nucleotid
substitut
decreas
reassort
process
might
affect
frequent
chang
antigen
preval
aiv
strain
better
condit
need
reassort
process
subtyp
aiv
proceed
addit
consist
gao
research
bind
affin
link
sialic
acid
receptor
subtyp
aiv
decreas
mainli
due
lack
nglycosyl
site
amino
acid
posit
ha
protein
influenza
viru
wide
host
rang
new
nglycosyl
site
found
indic
subtyp
aiv
might
attempt
adapt
differ
host
importantli
subtyp
aiv
adapt
mammal
pose
public
health
concern
mammal
human
henc
ongo
surveil
subtyp
aiv
bird
warrant
author
declar
compet
financi
interest
read
great
interest
recent
public
xie
et
al
address
issu
nextgener
sequenc
ng
diagnosi
sever
pneumonia
china
suggest
ng
might
lead
rapid
accur
diagnosi
better
clinic
prognosi
convent
detect
method
sever
pneumonia
icu
ng
novel
method
dnarna
sequenc
due
highthroughput
capac
fast
turnov
time
ng
technolog
wide
appli
field
medic
microbiolog
recent
year
ng
report
applic
pathogen
detect
blood
cerebrospin
fluid
tissu
intraop
sampl
howev
studi
report
bronchoalveolar
lavag
fluid
balf
sampl
communityacquir
pneumonia
cap
patient
immuno
suppress
compar
immunocompet
host
cap
potenti
fatal
present
signific
challeng
immunocompromis
host
ich
addit
common
pathogen
unusu
organ
caus
sever
infect
ich
besid
multipl
concurr
infect
also
common
ich
characterist
pose
sever
challeng
establish
specif
diagnosi
guid
therapi
diagnost
tool
pursu
aggress
favor
outcom
popul
recent
explor
util
ng
bronchoalveolar
lavag
diagnosi
pneumonia
immunocompromis
patient
thirteen
immunocompromis
patient
diagnosi
communtyacquir
pneumonia
cap
recruit
critic
care
depart
shanghai
ruijin
hospit
diagnosi
cap
base
presenc
select
clinic
featur
eg
cough
fever
sputum
product
pleurit
chest
pain
support
imag
lung
usual
chest
radiographi
immunosuppress
defin
chemotherapi
neutropenia
past
day
treatment
mg
corticosteroid
daili
day
human
immunodefici
viru
infect
immunosuppress
therapi
organ
bone
marrow
transplant
activ
tuberculosi
fiberopt
bronchoscopi
perform
local
anesthesia
topic
lidocain
patient
balf
specimen
use
three
aliquot
ml
salin
obtain
first
discard
recommend
other
pool
separ
two
aliquot
one
aliquot
sent
microbiolog
lab
direct
examin
gram
stain
cultur
one
sent
dna
extract
sequenc
standard
procedur
sp
balf
microbiolog
test
perform
patient
includ
quantit
cultur
bacteria
mycobacteria
fungi
addit
multiplex
pcr
influenza
ab
parainfluenza
coronaviru
coronaviru
respiratori
syncyti
viru
ab
adenoviru
human
metapneumoviru
human
rhinoviru
enteroviru
human
bocaviru
perform
balf
nasopharyng
cmv
ebv
hsvi
hsvii
serolog
igg
igm
antibodi
measur
clinic
characterist
includ
sex
age
apach
ii
score
time
diagnosi
cap
demonstr
tabl
patient
consid
immunocompromis
due
corticosteroid
therapi
immunosuppress
drug
sp
identifi
pathogen
patient
four
bacteria
one
fungi
one
viru
detect
clinic
respiratori
viral
pcr
panel
tabl
worth
note
two
sampl
posit
acinetobact
baumannii
sp
consid
coinfect
tabl
nextgener
sequenc
balf
patient
pneumonia
pjp
cmv
respect
ng
ng
detect
pathogen
patient
one
sampl
noninfecti
etiolog
confirm
ng
tabl
importantli
five
pjp
infect
one
aspergillu
fumigatu
infect
recogn
ng
moreov
among
six
fungiposit
sampl
cmv
also
identifi
three
two
pjp
one
aspergillu
fumigatu
rel
uncommon
pathogen
among
immunocompromis
pjp
identifi
case
cmv
case
ng
howev
cmv
serolog
igm
neg
patient
methenamin
silver
stain
perform
case
detect
item
carri
hospit
overal
four
bacteria
one
fungu
one
viru
detect
sp
comparison
four
bacteria
seven
fungi
five
virus
identifi
ng
tabl
term
bacteria
detect
ng
show
signific
advantag
studi
noteworthi
studi
demonstr
ng
distinct
advantag
field
fungi
viral
test
especi
pjp
cmv
detect
definit
pjp
diagnosi
usual
requir
demonstr
fungu
tissu
balf
induc
sputum
sampl
methenamin
silver
stain
pcr
balf
sampl
good
sensit
specif
emerg
modal
diagnosi
correct
clinic
set
laboratori
test
detect
cmv
infect
histopatholog
analysi
viral
cultur
tissu
blood
urin
respiratori
specimen
less
util
poor
sensit
longer
timeconsum
cmv
serolog
igg
igm
antibodi
anoth
diagnost
tool
may
neg
inconclus
immunocompromis
host
method
pcr
antigenemia
assay
carri
wide
ng
technolog
show
remark
advantag
term
opportunist
pathogen
patient
immunocompromis
state
recent
year
clinician
increasingli
awar
problem
mix
infect
immunocompromis
host
howev
diagnosi
cooccurr
two
commonli
seen
opportunist
infect
difficult
immunocompromis
patient
lung
infiltr
worth
note
distinct
advantag
ng
concurr
detect
bacteria
fungi
virus
studi
standard
procedur
perform
poorli
detect
mix
infect
wherea
five
case
coinfect
bacteria
fungi
virus
identifi
ng
advantag
may
help
clinician
comprehens
evalu
patient
make
effect
treatment
conclus
studi
explor
applic
ng
microbiolog
diagnosi
cap
patient
immunosuppress
ng
technolog
show
remark
advantag
detect
opportunist
pathogen
mix
infect
patient
studi
protocol
approv
ruijin
hospit
ethic
committe
shanghai
jiaotong
univers
school
medicin
china
formal
consent
obtain
patient
next
kin
studi
support
nation
key
r
program
china
nation
natur
scienc
foundat
china
shanghai
sail
program
author
declar
conflict
interest
